Azelnidipine inhibits cultured rat aortic smooth muscle cell death induced by cyclic mechanical stretch

PLoS ONE

Volumn 9, Issue 7, 2014, Pages

  Zhao, Jing ^a   Ozawa, Kentaro ^a   Kyotani, Yoji ^a   Nagayama, Kosuke ^a   Ito, Satoyasu ^a   Komatsubara, Akira T ^a   Tsuji, Yuichi ^a   Yoshizumi, Masanori ^a  

^a NARA MEDICAL UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

4 (4 FLUOROPHENYL) 2 (4 METHYLSULFINYLPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; ANTHRA[1,9 CD]PYRAZOL 6(2H) ONE; AZELNIDIPINE; DIPHENYLIODONIUM SALT; MITOGEN ACTIVATED PROTEIN KINASE INHIBITOR; MITOGEN ACTIVATED PROTEIN KINASE P38; STRESS ACTIVATED PROTEIN KINASE; ANTHRA(1,9-CD)PYRAZOL-6(2H)-ONE; ANTHRACENE DERIVATIVE; ANTIOXIDANT; AZETIDINE 2 CARBOXYLIC ACID; CATION; DIHYDROPYRIDINE DERIVATIVE; ENZYME INHIBITOR; IMIDAZOLE DERIVATIVE; PYRIDINE DERIVATIVE;

ANIMAL CELL; ANIMAL TISSUE; AORTA DISSECTION; ARTICLE; BLOOD PRESSURE MEASUREMENT; CELL DEATH; CELL VIABILITY; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DRUG MECHANISM; ENZYME ACTIVATION; IN VITRO STUDY; INHIBITION KINETICS; INTRACELLULAR SIGNALING; MALE; MECHANICAL STRESS; NONHUMAN; RAT; SMOOTH MUSCLE FIBER; ANALOGS AND DERIVATIVES; ANIMAL; AORTA; BLOOD PRESSURE; CELL CULTURE; DRUG EFFECTS; METABOLISM; SMOOTH MUSCLE CELL; SPRAGUE DAWLEY RAT; VASCULAR SMOOTH MUSCLE;

ANIMALS; ANTHRACENES; ANTIOXIDANTS; AORTA; AZETIDINECARBOXYLIC ACID; BLOOD PRESSURE; CELLS, CULTURED; DIHYDROPYRIDINES; ENZYME INHIBITORS; IMIDAZOLES; JNK MITOGEN-ACTIVATED PROTEIN KINASES; MALE; MUSCLE, SMOOTH, VASCULAR; MYOCYTES, SMOOTH MUSCLE; ONIUM COMPOUNDS; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PYRIDINES; RATS; RATS, SPRAGUE-DAWLEY;

EID: 84904489189     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0102813     Document Type: Article

References (29)

1. Wang JC, Bennett M (2012) Aging and atherosclerosis: mechanisms, functional consequences, and potential therapeutics for cellular senescence. Circ Res 111: 245-259.
2. Costopoulos C, Liew TV (2008) Bennett M. Ageing and atherosclerosis: Mechanisms and therapeutic options. Biochem Pharmacol 75: 1251-1261. (Pubitemid 351313894)
3. Guilmet D, Bachet J, Goudot B, Dreyfus G, Martinelli GL (1993) Aortic dissection: anatomic types and surgical approaches. J. Cardiovasc Surg 34: 23-32. (Pubitemid 23166303)
4. Fares A (2013) Winter cardiovascular diseases phenomenon N Am J Med Sci 5: 266-279.
5. Collins MJ, Dev V, Strauss BH, Fedak PW, Butany J (2007) Variation in the histopathological features of patients with ascending aortic aneurysms: a study of 111 surgically excised cases. Clin Pathol. 61: 519-523. (Pubitemid 351518238)
6. Wernig F, Mayr M, Xu Q (2003) Mechanical stretch-induced apoptosis in smooth muscle cells is mediated by beta1-integrin signaling pathways. Hypertension 41: 903-911. (Pubitemid 36418464)
7. Cheng WP, Wang BW, Chen SC, Chang H, Shyu KG (2012) Mechanical stretch induces the apoptosis regulator PUMA in vascular smooth muscle cells. Cardiovasc Res 93: 181-189.
8. Hipper A, Isenberg G (2000) Cyclic mechanical strain decreases the DNA synthesis of vascular smooth muscle cells. Pflugers Arch 440: 19-27. (Pubitemid 30265906)
9. Eguchi K, Tomizawa H, Ishikawa J, Hoshide S, Fukuda T, et al. (2007) Effects of new calcium channel blocker, azelnidipine, and amlodipine on baroreflex sensitivity and ambulatory blood pressure. J Cardiovasc Pharmacol 49: 394-400. (Pubitemid 47000314)
10. Oizumi K, Nishino H, Koike H, Sada T, Miyamoto M, et al. (1989) Antihypertensive effects of CS-905, a novel dihydropyridine Ca++ channel blocker. Jpn J Pharmacol 51: 57-64. (Pubitemid 19217326)
11. Zhao X, Wu F, Jia S, Qu P, Li H, et al. (2010) Azelnidipine and amlodipine: a comparison of their effects and safety in a randomized double-blinded clinical trial in Chinese essential hypertensive patients. Clin Exp Hypertens 32: 372-376.
12. Kondo N, Kiyomoto H, Yamamoto T, Miyatake A, Sun GP, et al. (2006) Effects of calcium channel blockade on angiotensin II-induced peritubular ischemia in rats. J Pharmacol Exp Ther 316: 1047-1052. (Pubitemid 43345277)
13. Fujimoto S, Satoh M, Nagasu H, Horike H, Sasaki T, et al. (2009) Azelnidipine exerts renoprotective effects by improvement of renal microcirculation in angiotensin II infusion rats. Nephrol Dial Transplant 24: 3651-3658.
14. Oizumi K, Nishino H, Miyake S, Shiga H, Sada T, et al. (1990) Hemodynamic changes following long-term administration of CS-905, a novel dihydropyridine calcium blocker, in conscious SHR. Jpn J Pharmacol 54: 1-6. (Pubitemid 20259969)
15. Satoh K, Yamamoto A, Hoshi K, Ichihara K (1998) Effects of azelnidipine, a dihydropyridine calcium antagonist, on myocardial stunning in dogs. Jpn J Pharmacol 76: 369-376. (Pubitemid 28227079)
16. Yoshizumi M, Abe J, Haendeler J, Huang Q, Berk BC (2000) Src and Cas mediate JNK activation but not ERK1/2 and p38 kinases by reactive oxygen species. J Biol Chem 275: 11706-11712. (Pubitemid 30237733)
17. Nakayama H, Zhao J, Ei-Fakhrany A, Isosaki M, Satoh H, et al. (2009) Neuroprotective effects of pramipexole against tunicamycin-induced cell death in PC12 cells. Clin Exp Pharmacol Physiol 36: 1183-1185.
18. Cornelissen J, Armstrong J, Holt CM (2004) Mechanical stretch induces phosphorylation of p38-MAPK and apoptosis in human saphenous vein. Arterioscler Thromb Vasc Biol 24: 451-456. (Pubitemid 38326137)
19. Hamada K, Takuwa N, Yokoyama K, Takuwa Y (1998) Stretch activates Jun N-terminal kinase/stress-activated protein kinase in vascular smooth muscle cells through mechanisms involving autocrine ATP stimulation of purinoceptors. J Biol Chem 273: 6334-6340. (Pubitemid 28144724)
20. Kurobe H, Matsuoka Y, Hirata Y, Sugasawa N, Maxfield MW, et al. (2013) Azelnidipine suppresses the progression of aortic aneurysm in wild mice model through anti-inflammatory effects. J Thorac Cardiovasc Surg 146: 1501-1508.
21. Ohyama T, Sato K, Kishimoto K, Yamazaki Y, Horiguchi N, et al. (2012) Azelnidipine is a calcium blocker that attenuates liver fibrosis and may increase antioxidant defence. Br J Pharmacol 165: 1173-1187.
22. Su BY, Shontz KM, Flavahan NA, Nowicki PT (2006) The effect of phenotype on mechanical stretch-induced vascular smooth muscle cell apoptosis. J Vasc Res 43: 229-237. (Pubitemid 44257042)
23. Song Jt, Hu B, Qu Hy, Bi Cl, Huang Xz, et al. (2012) Mechanical stretch modulates microRNA 21 expression, participating in proliferation and apoptosis in cultured human aortic smooth muscle cells. PLoS One 7: e47657.
24. Chahine MN, Dibrov E, Blackwood DP, Pierce GN (2012) Oxidized LDL enhances stretch-induced smooth muscle cell proliferation through alterations in nuclear protein import. Can J Physiol Pharmacol 90: 1559-1568.
25. Iryo Y, Matsuoka M, Wispriyono B, Sugiura T, Igisu H (2000) Involvement of the extracellular signal-regulated protein kinase (ERK) pathway in the induction of apoptosis by cadmium chloride in CCRF-CEM cells. Biochem Pharmacol 60: 1875-1882.
26. Huh JE, Kang KS, Chae C, Kim HM, Ahn KS, et al. (2004) Roles of p38 and JNK mitogen-activated protein kinase pathways during cantharidin-induced apoptosis in U937 cells. Biochem Pharmacol 67: 1811-1818. (Pubitemid 38591370)
27. Kim BC, Kim HG, Lee SA, Lim S, Park EH, et al. (2005) Genipin-induced apoptosis in hepatoma cells is mediated by reactive oxygen species/c-Jun NH2-terminal kinase-dependent activation of mitochondrial pathway. Biochem Pharmacol 70: 1398-1407. (Pubitemid 41383476)
28. Yoshimura K, Aoki H, Ikeda Y, Furutani A, Hamano K, et al. (2006) Regression of abdominal aortic aneurysm by inhibition of c-Jun N-terminal kinase in mice. Ann N Y Acad Sci 1085: 74-81. (Pubitemid 47092002)
29. Kyaw M, Yoshizumi M, Tsuchiya K, Kirima K, Tamaki T. (2001) Antioxidants inhibit JNK and p38 MAPK activation but not ERK 1/2 activation by angiotensin II in rat aortic smooth muscle cells. Hypertens Res. 24: 251-261. (Pubitemid 32577147)